首页 > 最新文献

JOURNAL OF MEDICAL INVESTIGATION最新文献

英文 中文
Potential effect of Ninjin'yoeito on the postoperative state of hepatectomy in a naturally aged mouse model of frailty. 忍仁益汤对自然衰老虚弱小鼠肝切除术后状态的潜在影响。
IF 0.8 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-01 DOI: 10.2152/jmi.72.245
Shinichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saito, Hiroki Teraoku, Katsuki Miyazaki, Mitsuo Shimada

Background: The number of elderly patients with frailty who require hepatectomy is increasing. This study aimed to investigate the effect of Ninjin'yoeito (NYT) on the post-hepatectomy state in naturally aged frailty model mice.

Methods: Seventy-two-week-old mice were subjected to 70% partial hepatectomy and then divided into an NYT-treated group and a control group. Mice were sacrificed immediately (0 hours) or 24 or 48 hours after hepatectomy. Body weight, grip strength, endurance, and survival duration were investigated. Furthermore, liver function was assessed, and mRNA expression was measured using reverse-transcription PCR.

Results: The body weight tended to be higher in the NYT group than in the control group 24 hours after hepatectomy (p=0.09). The grip strength was significantly stronger in the NYT group before and 48 hours after hepatectomy (p<0.05). Although survival time was slightly prolonged in the NYT group, there was no significant difference between the two groups. HMGB1 mRNA expression in the liver was significantly suppressed in the NYT group compared with that in the control group at 24 and 48 hours after hepatectomy (p<0.05).

Conclusions: NYT may affect the postoperative state, including body weight and motor function, in aged model mice. Suppression of HMGB1 might affect postoperative survival. J. Med. Invest. 72 : 245-251, August, 2025.

背景:老年虚弱患者需要肝切除术的人数正在增加。本研究旨在探讨忍仁益藤(NYT)对自然衰老虚弱模型小鼠肝切除后状态的影响。方法:72周龄小鼠肝部分切除70%,分为nyt治疗组和对照组。小鼠在肝切除术后立即(0小时)或24、48小时处死。研究了体重、握力、耐力和生存时间。此外,评估肝功能,并使用反转录PCR检测mRNA表达。结果:肝切除术后24 h, NYT组体重有高于对照组的趋势(p=0.09)。NYT组肝切除术前和术后48 h握力明显增强(p结论:NYT可能影响老龄模型小鼠术后状态,包括体重和运动功能。抑制HMGB1可能影响术后生存。[j] .中国医学杂志,2015,31(2):445 - 451。
{"title":"Potential effect of Ninjin'yoeito on the postoperative state of hepatectomy in a naturally aged mouse model of frailty.","authors":"Shinichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saito, Hiroki Teraoku, Katsuki Miyazaki, Mitsuo Shimada","doi":"10.2152/jmi.72.245","DOIUrl":"https://doi.org/10.2152/jmi.72.245","url":null,"abstract":"<p><strong>Background: </strong>The number of elderly patients with frailty who require hepatectomy is increasing. This study aimed to investigate the effect of Ninjin'yoeito (NYT) on the post-hepatectomy state in naturally aged frailty model mice.</p><p><strong>Methods: </strong>Seventy-two-week-old mice were subjected to 70% partial hepatectomy and then divided into an NYT-treated group and a control group. Mice were sacrificed immediately (0 hours) or 24 or 48 hours after hepatectomy. Body weight, grip strength, endurance, and survival duration were investigated. Furthermore, liver function was assessed, and mRNA expression was measured using reverse-transcription PCR.</p><p><strong>Results: </strong>The body weight tended to be higher in the NYT group than in the control group 24 hours after hepatectomy (p=0.09). The grip strength was significantly stronger in the NYT group before and 48 hours after hepatectomy (p<0.05). Although survival time was slightly prolonged in the NYT group, there was no significant difference between the two groups. HMGB1 mRNA expression in the liver was significantly suppressed in the NYT group compared with that in the control group at 24 and 48 hours after hepatectomy (p<0.05).</p><p><strong>Conclusions: </strong>NYT may affect the postoperative state, including body weight and motor function, in aged model mice. Suppression of HMGB1 might affect postoperative survival. J. Med. Invest. 72 : 245-251, August, 2025.</p>","PeriodicalId":46910,"journal":{"name":"JOURNAL OF MEDICAL INVESTIGATION","volume":"72 3.4","pages":"245-251"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145439675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The combination of CD8 and TIM3 expression predicts survival outcomes in hepatocellular carcinoma. CD8和TIM3的联合表达预测肝细胞癌的生存结局。
IF 0.8 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-01 DOI: 10.2152/jmi.72.354
Takayuki Noma, Yuma Wada, Masaaki Nishi, Hiroki Teraoku, Shinichiro Yamada, Yu Saito, Tetsuya Ikemoto, Yuji Morine, Mitsuo Shimada

Background: Tumor-infiltrating CD8+ T cells express many immune checkpoint proteins and are currently the focus of therapeutic targeting, although dramatic results have not yet been achieved in hepatocellular carcinoma (HCC). In this study, we performed a statistical analysis of immune checkpoint proteins and prognosis in HCC to evaluate its utility as a biomarker for predicting prognosis.

Methods: We analyzed 474 HCC patients with two comprehensive miRNA profiling datasets (GSE76427:n=115 and TCGA:n=359) with clinical and transcriptomic data to examine associations between mRNA levels of CD8, TIM3, and PD-1/PD-L1. Each gene was divided into low- and high-expression groups using the tertiles of RNA expression.

Results: CD8 and TIM3 expression were associated with overall survival (OS) (P=0.021 and P=0.025, respectively), while PD-1/PD-L1 levels were not associated with OS (P=0.306 and P=0.318, respectively) in TCGA dataset. Among patients with high CD8 expression, low TIM3 expression was associated with better OS (TCGA:P=0.009, Whole patient cohort (TCGA+GSE dataset):P=0.008).

Conclusions: The combination of CD8 and TIM3 expression which indicates T cell exhaustion was useful biomarker for predicting HCC prognosis than PD-1/PD-L1, suggesting that TIM3 may be a future target for immune checkpoint inhibition. J. Med. Invest. 72 : 354-360, August, 2025.

背景:肿瘤浸润性CD8+ T细胞表达许多免疫检查点蛋白,目前是靶向治疗的焦点,尽管在肝细胞癌(HCC)中尚未取得显著的结果。在这项研究中,我们对HCC中免疫检查点蛋白和预后进行了统计分析,以评估其作为预测预后的生物标志物的效用。方法:我们分析了474例HCC患者的两个综合miRNA分析数据集(GSE76427:n=115和TCGA:n=359)的临床和转录组学数据,以检查CD8, TIM3和PD-1/PD-L1 mRNA水平之间的关系。根据RNA表达的位数将每个基因分为低表达组和高表达组。结果:TCGA数据集中CD8和TIM3表达与总生存期(OS)相关(P=0.021和P=0.025),而PD-1/PD-L1水平与OS无关(P=0.306和P=0.318)。在CD8高表达的患者中,TIM3低表达与较好的OS相关(TCGA:P=0.009,全患者队列(TCGA+GSE数据集):P=0.008)。结论:与PD-1/PD-L1相比,CD8和TIM3联合表达(表明T细胞衰竭)是预测HCC预后的有用生物标志物,提示TIM3可能是免疫检查点抑制的未来靶点。[j] .医药科学与工程,2016。
{"title":"The combination of CD8 and TIM3 expression predicts survival outcomes in hepatocellular carcinoma.","authors":"Takayuki Noma, Yuma Wada, Masaaki Nishi, Hiroki Teraoku, Shinichiro Yamada, Yu Saito, Tetsuya Ikemoto, Yuji Morine, Mitsuo Shimada","doi":"10.2152/jmi.72.354","DOIUrl":"https://doi.org/10.2152/jmi.72.354","url":null,"abstract":"<p><strong>Background: </strong>Tumor-infiltrating CD8+ T cells express many immune checkpoint proteins and are currently the focus of therapeutic targeting, although dramatic results have not yet been achieved in hepatocellular carcinoma (HCC). In this study, we performed a statistical analysis of immune checkpoint proteins and prognosis in HCC to evaluate its utility as a biomarker for predicting prognosis.</p><p><strong>Methods: </strong>We analyzed 474 HCC patients with two comprehensive miRNA profiling datasets (GSE76427:n=115 and TCGA:n=359) with clinical and transcriptomic data to examine associations between mRNA levels of CD8, TIM3, and PD-1/PD-L1. Each gene was divided into low- and high-expression groups using the tertiles of RNA expression.</p><p><strong>Results: </strong>CD8 and TIM3 expression were associated with overall survival (OS) (P=0.021 and P=0.025, respectively), while PD-1/PD-L1 levels were not associated with OS (P=0.306 and P=0.318, respectively) in TCGA dataset. Among patients with high CD8 expression, low TIM3 expression was associated with better OS (TCGA:P=0.009, Whole patient cohort (TCGA+GSE dataset):P=0.008).</p><p><strong>Conclusions: </strong>The combination of CD8 and TIM3 expression which indicates T cell exhaustion was useful biomarker for predicting HCC prognosis than PD-1/PD-L1, suggesting that TIM3 may be a future target for immune checkpoint inhibition. J. Med. Invest. 72 : 354-360, August, 2025.</p>","PeriodicalId":46910,"journal":{"name":"JOURNAL OF MEDICAL INVESTIGATION","volume":"72 3.4","pages":"354-360"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145439691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immune checkpoint inhibitor-associated paraneoplastic cerebellar degeneration in a case of extensive-stage small-cell lung cancer with pre-existing anti-SOX1 antibody. 存在抗sox1抗体的广泛期小细胞肺癌的免疫检查点抑制剂相关的副肿瘤小脑变性
IF 0.7 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-01 DOI: 10.2152/jmi.72.172
Kaori Nii, Hirokazu Ogino, Hiroki Bando, Yuki Yamamoto, Koji Fujita, Hiroto Yoneda, Nobuhito Naito, Atsushi Mitsuhashi, Yutaka Morita, Yuki Tsukazaki, Yohei Yabuki, Ryohiko Ozaki, Seidai Sato, Masaki Hanibuchi, Yuishin Izumi, Yasuhiko Nishioka

Neurological immune-related adverse events can manifest as paraneoplastic neurological syndrome (PNS), especially in patients with small-cell lung cancer (SCLC). We herein report a 73-year-old man with SCLC treated with an immune checkpoint inhibitor (ICI) combined with chemotherapy. Although the chemo-immunotherapy induced a favorable response to SCLC, he later developed acute cerebellar ataxia. He was diagnosed with paraneoplastic cerebellar degeneration associated with anti-Sry-like high mobility group box 1 (SOX1) autoantibody. The antibody was also identified in serum collected at the diagnosis of SCLC and before ICI administration, which retrospectively suggested that the patient was at risk of ICI-induced PNS. J. Med. Invest. 72 : 172-176, February, 2025.

神经免疫相关不良事件可表现为副肿瘤神经综合征(PNS),特别是在小细胞肺癌(SCLC)患者中。我们在此报告一位73岁的SCLC患者,接受免疫检查点抑制剂(ICI)联合化疗治疗。尽管化疗免疫治疗对SCLC有良好的反应,但他后来出现了急性小脑性共济失调。诊断为副肿瘤小脑变性伴抗sry样高迁移率组盒1 (SOX1)自身抗体。在SCLC诊断时和给药前收集的血清中也发现了该抗体,回顾性提示患者存在ICI诱导的PNS风险。中华医学杂志。32(2):772 - 776,2025。
{"title":"Immune checkpoint inhibitor-associated paraneoplastic cerebellar degeneration in a case of extensive-stage small-cell lung cancer with pre-existing anti-SOX1 antibody.","authors":"Kaori Nii, Hirokazu Ogino, Hiroki Bando, Yuki Yamamoto, Koji Fujita, Hiroto Yoneda, Nobuhito Naito, Atsushi Mitsuhashi, Yutaka Morita, Yuki Tsukazaki, Yohei Yabuki, Ryohiko Ozaki, Seidai Sato, Masaki Hanibuchi, Yuishin Izumi, Yasuhiko Nishioka","doi":"10.2152/jmi.72.172","DOIUrl":"https://doi.org/10.2152/jmi.72.172","url":null,"abstract":"<p><p>Neurological immune-related adverse events can manifest as paraneoplastic neurological syndrome (PNS), especially in patients with small-cell lung cancer (SCLC). We herein report a 73-year-old man with SCLC treated with an immune checkpoint inhibitor (ICI) combined with chemotherapy. Although the chemo-immunotherapy induced a favorable response to SCLC, he later developed acute cerebellar ataxia. He was diagnosed with paraneoplastic cerebellar degeneration associated with anti-Sry-like high mobility group box 1 (SOX1) autoantibody. The antibody was also identified in serum collected at the diagnosis of SCLC and before ICI administration, which retrospectively suggested that the patient was at risk of ICI-induced PNS. J. Med. Invest. 72 : 172-176, February, 2025.</p>","PeriodicalId":46910,"journal":{"name":"JOURNAL OF MEDICAL INVESTIGATION","volume":"72 1.2","pages":"172-176"},"PeriodicalIF":0.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144041826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of 69 Hepatocellular Carcinoma Cases from the National Center for Pathology in Mongolia : A Comprehensive Study of Samples Collected Nationwide. 蒙古国家病理中心69例肝细胞癌病例分析:全国样本综合研究
IF 0.7 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-01 DOI: 10.2152/jmi.72.47
Orgil Jargalsaikhan, Wenhua Shao, Mayuko Ichimura-Shimizu, Soichiro Ishimaru, Takaaki Koma, Masako Nomaguchi, Battogtokh Chimeddorj, Khongorzul Batchuluun, Ganzorig Batbaatar, Gankhuu Gankhuyag, Saruul Gerelchuluun, Minoru Irahara, Masashi Akaike, Koichi Tsuneyama

The high rate of chronic hepatitis, including hepatitis B, C and D, in Mongolia creates a large health burden of advanced liver disease. This includes liver failure and the highest incidence rate of hepatocellular carcinoma (HCC) worldwide. In the present study, we histopathologically examined 69 recent cases of HCC from the Mongolian National Center for Pathology, which collects specimens from across the country. The background liver histology of HCC exhibited a bimodal distribution, with one peak corresponding to advanced liver fibrosis and another to mild liver fibrosis. The fibrosis severity negatively correlated with age. Additionally, the frequency of poorly differentiated tumors was significantly higher in the HCC with early stage of fibrosis. A comparison of the pathological characteristics of HCC in urban and rural areas showed that poorly differentiated tumors were highly prevalent in urban areas. The characteristics of HCC in Mongolia are different from those in other countries, suggesting that the causes of liver disease are not only related to viruses but also other factors that depend on the region. This study will provide insight into what research is needed next for liver cancer control in Mongolia. J. Med. Invest. 72 : 47-53, February, 2025.

蒙古慢性肝炎(包括乙型、丙型和丁型肝炎)的高发病率造成了严重的晚期肝病健康负担。这包括肝衰竭和世界范围内发病率最高的肝细胞癌(HCC)。在本研究中,我们对来自蒙古国家病理中心的69例HCC进行了组织病理学检查,该中心收集了来自全国各地的标本。HCC的肝脏组织学表现为双峰分布,一个峰对应晚期肝纤维化,另一个峰对应轻度肝纤维化。纤维化严重程度与年龄呈负相关。此外,HCC伴早期纤维化的低分化肿瘤发生率明显较高。通过对城市和农村HCC病理特征的比较发现,低分化肿瘤在城市地区非常普遍。蒙古国HCC的特点与其他国家不同,提示肝脏疾病的病因不仅与病毒有关,还与其他取决于地区的因素有关。这项研究将为蒙古下一步需要进行的肝癌控制研究提供见解。中华医学杂志,2015年2月。
{"title":"Analysis of 69 Hepatocellular Carcinoma Cases from the National Center for Pathology in Mongolia : A Comprehensive Study of Samples Collected Nationwide.","authors":"Orgil Jargalsaikhan, Wenhua Shao, Mayuko Ichimura-Shimizu, Soichiro Ishimaru, Takaaki Koma, Masako Nomaguchi, Battogtokh Chimeddorj, Khongorzul Batchuluun, Ganzorig Batbaatar, Gankhuu Gankhuyag, Saruul Gerelchuluun, Minoru Irahara, Masashi Akaike, Koichi Tsuneyama","doi":"10.2152/jmi.72.47","DOIUrl":"https://doi.org/10.2152/jmi.72.47","url":null,"abstract":"<p><p>The high rate of chronic hepatitis, including hepatitis B, C and D, in Mongolia creates a large health burden of advanced liver disease. This includes liver failure and the highest incidence rate of hepatocellular carcinoma (HCC) worldwide. In the present study, we histopathologically examined 69 recent cases of HCC from the Mongolian National Center for Pathology, which collects specimens from across the country. The background liver histology of HCC exhibited a bimodal distribution, with one peak corresponding to advanced liver fibrosis and another to mild liver fibrosis. The fibrosis severity negatively correlated with age. Additionally, the frequency of poorly differentiated tumors was significantly higher in the HCC with early stage of fibrosis. A comparison of the pathological characteristics of HCC in urban and rural areas showed that poorly differentiated tumors were highly prevalent in urban areas. The characteristics of HCC in Mongolia are different from those in other countries, suggesting that the causes of liver disease are not only related to viruses but also other factors that depend on the region. This study will provide insight into what research is needed next for liver cancer control in Mongolia. J. Med. Invest. 72 : 47-53, February, 2025.</p>","PeriodicalId":46910,"journal":{"name":"JOURNAL OF MEDICAL INVESTIGATION","volume":"72 1.2","pages":"47-53"},"PeriodicalIF":0.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144053677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of raloxifene as a sequential therapy after romosozumab : an observational study. 罗莫索单抗后使用雷洛昔芬作为序贯治疗:一项观察性研究。
IF 0.7 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-01 DOI: 10.2152/jmi.72.124
Kazuaki Mineta, Toshihiko Nishisho, Masahiko Okada, Mitsuhiro Kamada, Koichi Sairyo

Objective: There have been no studies on the effectiveness of raloxifene as an antiresorptive agentfollowing discontinuation of romosozumab. The aim of this study was to investigate the potential effectiveness of raloxifene following a romosozumab therapy.

Methods: This study had an observational pre-post design and included 23 patients. Romosozumab 210 mg was administered subcutaneously once every 4 weeks for 12 months, after which all patients received raloxifene 60 mg/day for 24 months. We investigated the incidence of new fractures, safety, and bone mineral density (BMD).

Results: We found no new fractures or adverse events. After the treatment with romosozumab, percent changes from baseline in BMD at the spine and total hip in treatment-naïve patients with primary osteoporosis (the Naïve-P group) were 12.3% and 4.6%, respectively. After subsequent administration of raloxifene, spinal and total hip BMD in the Naïve-P group decreased to baseline levels at 36 months and 30 months, respectively. Six months after switching to raloxifene, the respective percent changes from baseline in spinal and total hip BMD were 12.0% and 5.8%.

Conclusion: Romosozumab followed by raloxifene is acceptable for use for only 6 months in the Naïve-P group. However, more aggressive use of this agent is not recommended. J. Med. Invest. 72 : 124-133, February, 2025.

目的:目前还没有关于雷洛昔芬在停药后作为抗吸收药物的有效性的研究。本研究的目的是调查雷洛昔芬在罗莫索单抗治疗后的潜在有效性。方法:本研究采用观察性前后设计,纳入23例患者。Romosozumab 210 mg,每4周皮下注射1次,持续12个月,之后所有患者接受雷洛昔芬60 mg/天,持续24个月。我们调查了新骨折的发生率、安全性和骨密度(BMD)。结果:我们没有发现新的骨折或不良事件。在接受romosozumab治疗后,treatment-naïve原发性骨质疏松症患者(Naïve-P组)脊柱和全髋关节骨密度较基线变化的百分比分别为12.3%和4.6%。随后给予雷洛昔芬后,Naïve-P组的脊柱和全髋关节骨密度分别在36个月和30个月时降至基线水平。改用雷洛昔芬6个月后,脊柱和髋部骨密度相对基线的变化百分比分别为12.0%和5.8%。结论:在Naïve-P组中,Romosozumab与雷洛昔芬联合使用仅可接受6个月。然而,不建议更积极地使用这种药物。中华医学杂志,2015,32(2):344 - 344。
{"title":"Use of raloxifene as a sequential therapy after romosozumab : an observational study.","authors":"Kazuaki Mineta, Toshihiko Nishisho, Masahiko Okada, Mitsuhiro Kamada, Koichi Sairyo","doi":"10.2152/jmi.72.124","DOIUrl":"10.2152/jmi.72.124","url":null,"abstract":"<p><strong>Objective: </strong>There have been no studies on the effectiveness of raloxifene as an antiresorptive agentfollowing discontinuation of romosozumab. The aim of this study was to investigate the potential effectiveness of raloxifene following a romosozumab therapy.</p><p><strong>Methods: </strong>This study had an observational pre-post design and included 23 patients. Romosozumab 210 mg was administered subcutaneously once every 4 weeks for 12 months, after which all patients received raloxifene 60 mg/day for 24 months. We investigated the incidence of new fractures, safety, and bone mineral density (BMD).</p><p><strong>Results: </strong>We found no new fractures or adverse events. After the treatment with romosozumab, percent changes from baseline in BMD at the spine and total hip in treatment-naïve patients with primary osteoporosis (the Naïve-P group) were 12.3% and 4.6%, respectively. After subsequent administration of raloxifene, spinal and total hip BMD in the Naïve-P group decreased to baseline levels at 36 months and 30 months, respectively. Six months after switching to raloxifene, the respective percent changes from baseline in spinal and total hip BMD were 12.0% and 5.8%.</p><p><strong>Conclusion: </strong>Romosozumab followed by raloxifene is acceptable for use for only 6 months in the Naïve-P group. However, more aggressive use of this agent is not recommended. J. Med. Invest. 72 : 124-133, February, 2025.</p>","PeriodicalId":46910,"journal":{"name":"JOURNAL OF MEDICAL INVESTIGATION","volume":"72 1.2","pages":"124-133"},"PeriodicalIF":0.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144034726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lipolysis-stimulated lipoprotein receptor is involved in fatty acid binding protein 4-mediated prostate cancer cell growth in bone. 脂溶刺激脂蛋白受体参与脂肪酸结合蛋白4介导的骨内前列腺癌细胞生长。
IF 0.7 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-01 DOI: 10.2152/jmi.72.34
Tetsuyuki Takahashi, Takaaki Tsunematsu, Hisanori Uehara

Obesity-induced excess adipokine production is associated with malignancy and mortality in prostate cancer. We previously showed that fatty acid binding protein 4 (FABP4), a major adipokine of mature adipocytes, promotes the progression of prostate cancer cell growth and invasion. In this report, we present lipolysis-stimulated lipoprotein receptor (LSR) as a newly identified binding partner for FABP4. Their binding induced Akt phosphorylation, whereas LSR knockdown (KD) failed to phosphorylate Akt. Intraosseous injection of LSR-KD prostate cancer cells showed smaller areas of intraosseous tumor, lower Ki-67 labeling indices, and lower numbers of phospho-Akt-positive cancer cells compared with control prostate cancer cells. Moreover, the contact coculture of prostate cancer cells with bone marrow stromal cells (BMSCs) promoted FABP4 secretion by BMSCs. Our findings indicated that FABP4-mediated prostate cancer cell progression was regulated by cellular signaling via FABP4-LSR binding in the bone microenvironment. J. Med. Invest. 72 : 34-41, February, 2025.

肥胖诱导的过量脂肪因子产生与前列腺癌的恶性和死亡率有关。我们之前的研究表明,脂肪酸结合蛋白4 (FABP4)是成熟脂肪细胞的主要脂肪因子,可促进前列腺癌细胞的生长和侵袭。在这篇报道中,我们提出了一个新发现的FABP4结合伙伴——脂肪酶刺激脂蛋白受体(LSR)。它们的结合诱导Akt磷酸化,而LSR敲低(KD)不能磷酸化Akt。骨内注射LSR-KD前列腺癌细胞,与对照前列腺癌细胞相比,骨内肿瘤面积更小,Ki-67标记指数更低,磷酸化akt阳性癌细胞数量更少。此外,前列腺癌细胞与骨髓基质细胞(BMSCs)接触共培养可促进骨髓基质细胞分泌FABP4。我们的研究结果表明,fabp4介导的前列腺癌细胞的进展是通过FABP4-LSR结合在骨微环境中的细胞信号传导来调节的。中华医学杂志,2002,26(2):34-41。
{"title":"Lipolysis-stimulated lipoprotein receptor is involved in fatty acid binding protein 4-mediated prostate cancer cell growth in bone.","authors":"Tetsuyuki Takahashi, Takaaki Tsunematsu, Hisanori Uehara","doi":"10.2152/jmi.72.34","DOIUrl":"https://doi.org/10.2152/jmi.72.34","url":null,"abstract":"<p><p>Obesity-induced excess adipokine production is associated with malignancy and mortality in prostate cancer. We previously showed that fatty acid binding protein 4 (FABP4), a major adipokine of mature adipocytes, promotes the progression of prostate cancer cell growth and invasion. In this report, we present lipolysis-stimulated lipoprotein receptor (LSR) as a newly identified binding partner for FABP4. Their binding induced Akt phosphorylation, whereas LSR knockdown (KD) failed to phosphorylate Akt. Intraosseous injection of LSR-KD prostate cancer cells showed smaller areas of intraosseous tumor, lower Ki-67 labeling indices, and lower numbers of phospho-Akt-positive cancer cells compared with control prostate cancer cells. Moreover, the contact coculture of prostate cancer cells with bone marrow stromal cells (BMSCs) promoted FABP4 secretion by BMSCs. Our findings indicated that FABP4-mediated prostate cancer cell progression was regulated by cellular signaling via FABP4-LSR binding in the bone microenvironment. J. Med. Invest. 72 : 34-41, February, 2025.</p>","PeriodicalId":46910,"journal":{"name":"JOURNAL OF MEDICAL INVESTIGATION","volume":"72 1.2","pages":"34-41"},"PeriodicalIF":0.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144034038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How should we intervene to increase the number of female spine surgeons? A preliminary survey of trainees in Japan from medical school through spine fellowship. 我们应该如何干预以增加女性脊柱外科医生的数量?日本医科大学脊柱研修生的初步调查。
IF 0.8 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-01 DOI: 10.2152/jmi.72.425
Saori Soeda, Nori Sato, Kosuke Sugiura, Hiroaki Manabe, Masatoshi Morimoto, Fumitake Tezuka, Kazuta Yamashita, Junzo Fujitani, Koichi Sairyo

Background: Women account for 23.6% of physicians in Japan yet account for only 5% of orthopedic surgeons and <1% of board-certified spine surgeons. We identified points along the training pathway where women perceive barriers to pursuing spine surgery.

Methods: In this sequential explanatory mixed-methods study, we surveyed all 5th- and 6th-year medical students at our institution and postgraduate year-1-2 residents and received responses from 62 trainees (29 women, 33 men). Counts, percentages, and χ2 or Fisher exact tests were used to compare the groups. We thematically analyzed the semi-structured e-mail interviews conducted with 10 female orthopedic trainees (4 residents, 1 non-spine surgeon, and 5 spine fellows).

Results: Interest in orthopedics was reported by 45% of women and 64% of men (p=0.22);within that subgroup interest in spine surgery was similar (31% vs. 33%;p=1.00). From the interviews, four categories of barriers to choosing spine surgery as a subspecialty emerged:(1) physical limitations, (2) radiation exposure, (3) demanding working hours/on‑call, and (4) a gender‑imbalanced environment.

Conclusions: Many early-career women already express interest in orthopedics. However, translating that interest into careers as spine surgeons will require sustained mentorship plus the adoption of assistive technologies, ergonomic instruments, and team-based shift schedules-interventions that could benefit the entire surgical workforce. J. Med. Invest. 72 : 425-429, August, 2025.

背景:女性占日本医生的23.6%,但仅占骨科医生的5%。方法:在这项顺序解释性混合方法研究中,我们调查了我们机构所有5年级和6年级的医学生以及1-2年级的研究生住院医师,并收到62名实习生(29名女性,33名男性)的反馈。采用计数、百分比、χ2或Fisher精确检验进行组间比较。我们对10名女性骨科实习生(4名住院医师、1名非脊柱外科医生和5名脊柱研究员)进行的半结构化电子邮件访谈进行了主题分析。结果:45%的女性和64%的男性对骨科感兴趣(p=0.22);在该亚组中,对脊柱手术的兴趣相似(31%对33%;p=1.00)。从访谈中,选择脊柱外科作为亚专业的四类障碍出现了:(1)身体限制,(2)辐射暴露,(3)工作时间长/随叫随到,(4)性别不平衡的环境。结论:许多早期职业女性已经表达了对骨科的兴趣。然而,将这种兴趣转化为脊柱外科医生的职业将需要持续的指导,以及采用辅助技术、人体工程学仪器和基于团队的轮班时间表——这些干预措施可以使整个外科工作人员受益。中华医学杂志,2015,31(2):425-429。
{"title":"How should we intervene to increase the number of female spine surgeons? A preliminary survey of trainees in Japan from medical school through spine fellowship.","authors":"Saori Soeda, Nori Sato, Kosuke Sugiura, Hiroaki Manabe, Masatoshi Morimoto, Fumitake Tezuka, Kazuta Yamashita, Junzo Fujitani, Koichi Sairyo","doi":"10.2152/jmi.72.425","DOIUrl":"https://doi.org/10.2152/jmi.72.425","url":null,"abstract":"<p><strong>Background: </strong>Women account for 23.6% of physicians in Japan yet account for only 5% of orthopedic surgeons and <1% of board-certified spine surgeons. We identified points along the training pathway where women perceive barriers to pursuing spine surgery.</p><p><strong>Methods: </strong>In this sequential explanatory mixed-methods study, we surveyed all 5th- and 6th-year medical students at our institution and postgraduate year-1-2 residents and received responses from 62 trainees (29 women, 33 men). Counts, percentages, and χ2 or Fisher exact tests were used to compare the groups. We thematically analyzed the semi-structured e-mail interviews conducted with 10 female orthopedic trainees (4 residents, 1 non-spine surgeon, and 5 spine fellows).</p><p><strong>Results: </strong>Interest in orthopedics was reported by 45% of women and 64% of men (p=0.22);within that subgroup interest in spine surgery was similar (31% vs. 33%;p=1.00). From the interviews, four categories of barriers to choosing spine surgery as a subspecialty emerged:(1) physical limitations, (2) radiation exposure, (3) demanding working hours/on‑call, and (4) a gender‑imbalanced environment.</p><p><strong>Conclusions: </strong>Many early-career women already express interest in orthopedics. However, translating that interest into careers as spine surgeons will require sustained mentorship plus the adoption of assistive technologies, ergonomic instruments, and team-based shift schedules-interventions that could benefit the entire surgical workforce. J. Med. Invest. 72 : 425-429, August, 2025.</p>","PeriodicalId":46910,"journal":{"name":"JOURNAL OF MEDICAL INVESTIGATION","volume":"72 3.4","pages":"425-429"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145439681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mid-term hemodynamic performance of INSPIRIS RESILIA aortic bioprosthesis for severe aortic stenosis. INSPIRIS RESILIA生物主动脉假体治疗重度主动脉狭窄的中期血流动力学表现。
IF 0.8 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-01 DOI: 10.2152/jmi.72.390
Naoto Fukunaga, Tatsuto Wakami, Akio Shimoji, Otohime Mori, Kosuke Yoshizawa, Nobushige Tamura

We investigated mid-term outcomes after aortic valve replacement (AVR) with INSPIRIS RESILIA (IR) aortic bioprosthesis for severe aortic stenosis (AS). A total of 60 patients with a mean age of 73.2±6.2 years underwent AVR with IR bioprosthesis for severe AS. We prospectively followed up on 59 survivors and collected transthoracic echocardiographic data at 3-6 months, and annually thereafter. The mean follow-up period was 3.0±1.5 years, with a 100% follow-up rate. The preoperative mean pressure gradient (PG) and the effective orifice area were 52.5±18.2 mmHg, and 0.73±0.23 cm2, respectively, which improved to 10.3±3.5 mmHg (P<0.001), and 1.85±0.48 cm2 (P<0.001) at discharge. The mean PG at 5 years was 10.2±2.7 mmHg, which was similar to one at discharge (P=0.307). Left ventricular mass index decreased from 119.6±33.1 g/m2 before AVR to 104.0±32.5 g/m2 (P<0.001) at discharge, and further decreased to 78.5±22.2 g/m2 at 5 years compared with postoperative one (P=0.011). Survival rate at 5 years was 97.4±2.6%. Freedom from valve-related events at 5 years was 91.4±5.5%. Incidental cerebral infarction (n=2) and heart failure (n=1) were noted. IR bioprosthesis demonstrated a stable hemodynamic performance and few valve-related events. J. Med. Invest. 72 : 390-395, August, 2025.

我们研究了重度主动脉瓣狭窄(AS)采用INSPIRIS RESILIA (IR)生物主动脉假体进行主动脉瓣置换术(AVR)后的中期预后。共有60例患者(平均年龄73.2±6.2岁)行AVR + IR生物假体治疗严重AS。我们对59名幸存者进行了前瞻性随访,并收集了3-6个月的经胸超声心动图数据,此后每年一次。平均随访时间3.0±1.5年,随访率100%。术前平均压力梯度(PG)为52.5±18.2 mmHg,有效孔面积为0.73±0.23 cm2,术前平均压力梯度(PG)为10.3±3.5 mmHg (P
{"title":"Mid-term hemodynamic performance of INSPIRIS RESILIA aortic bioprosthesis for severe aortic stenosis.","authors":"Naoto Fukunaga, Tatsuto Wakami, Akio Shimoji, Otohime Mori, Kosuke Yoshizawa, Nobushige Tamura","doi":"10.2152/jmi.72.390","DOIUrl":"https://doi.org/10.2152/jmi.72.390","url":null,"abstract":"<p><p>We investigated mid-term outcomes after aortic valve replacement (AVR) with INSPIRIS RESILIA (IR) aortic bioprosthesis for severe aortic stenosis (AS). A total of 60 patients with a mean age of 73.2±6.2 years underwent AVR with IR bioprosthesis for severe AS. We prospectively followed up on 59 survivors and collected transthoracic echocardiographic data at 3-6 months, and annually thereafter. The mean follow-up period was 3.0±1.5 years, with a 100% follow-up rate. The preoperative mean pressure gradient (PG) and the effective orifice area were 52.5±18.2 mmHg, and 0.73±0.23 cm2, respectively, which improved to 10.3±3.5 mmHg (P<0.001), and 1.85±0.48 cm2 (P<0.001) at discharge. The mean PG at 5 years was 10.2±2.7 mmHg, which was similar to one at discharge (P=0.307). Left ventricular mass index decreased from 119.6±33.1 g/m2 before AVR to 104.0±32.5 g/m2 (P<0.001) at discharge, and further decreased to 78.5±22.2 g/m2 at 5 years compared with postoperative one (P=0.011). Survival rate at 5 years was 97.4±2.6%. Freedom from valve-related events at 5 years was 91.4±5.5%. Incidental cerebral infarction (n=2) and heart failure (n=1) were noted. IR bioprosthesis demonstrated a stable hemodynamic performance and few valve-related events. J. Med. Invest. 72 : 390-395, August, 2025.</p>","PeriodicalId":46910,"journal":{"name":"JOURNAL OF MEDICAL INVESTIGATION","volume":"72 3.4","pages":"390-395"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145439705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A fatal infantile case with suspected hyperekplexia. 疑为过度臂丛的婴儿死亡病例1例。
IF 0.8 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-01 DOI: 10.2152/jmi.72.438
Yuri Hayashi, Miki Shono, Yuki Sato, Takuya Ohno, Akemi Ono, Makoto Irahara, Koichi Shichijo, Hiroyoshi Watanabe
{"title":"A fatal infantile case with suspected hyperekplexia.","authors":"Yuri Hayashi, Miki Shono, Yuki Sato, Takuya Ohno, Akemi Ono, Makoto Irahara, Koichi Shichijo, Hiroyoshi Watanabe","doi":"10.2152/jmi.72.438","DOIUrl":"https://doi.org/10.2152/jmi.72.438","url":null,"abstract":"","PeriodicalId":46910,"journal":{"name":"JOURNAL OF MEDICAL INVESTIGATION","volume":"72 3.4","pages":"438-439"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145439499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current State of Healthcare Robots for Older Adults in Care Facilities in Japan and the Related Ethical Issues for Nurses. 日本护理机构中老年人医疗保健机器人的现状以及护士的相关道德问题。
IF 0.7 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-01 DOI: 10.2152/jmi.72.8
Yuko Yasuhara

This review discusses the introduction of healthcare robots, such as those that provide transfer, toileting, bathing, and communication assistance, in Japanese facilities for older adults and considers these issues from the perspective of nursing ethics. Although healthcare robots can support older adults and their caregivers, they may cause ethical dilemmas when introduced in assisted living facilities. Nurses should make ethical decisions by considering different types of information to determine the best care for older adults ; they can resolve ethical dilemmas by referring to the 6 principles of nursing ethics. As healthcare robots are increasingly used in the care of older adults, nurses should protect patients' rights and ensure patient safety. Further, engineers and medical professionals must discuss and share issues related to the use of healthcare robots to build improved robotic technology for older adults. J. Med. Invest. 72 : 8-13, February, 2025.

这篇综述讨论了医疗保健机器人的引入,例如在日本老年人设施中提供转移、如厕、洗澡和沟通协助的机器人,并从护理伦理的角度考虑了这些问题。虽然医疗机器人可以支持老年人和他们的照顾者,但当它们被引入辅助生活设施时,可能会引起伦理困境。护士应该通过考虑不同类型的信息来做出道德决定,以确定对老年人的最佳护理;他们可以参考护理伦理的6条原则来解决伦理困境。随着医疗机器人越来越多地用于老年人的护理,护士应该保护患者的权利,确保患者的安全。此外,工程师和医疗专业人员必须讨论和分享与使用医疗机器人相关的问题,为老年人建立改进的机器人技术。中华医学杂志,2015,32(2):813 - 813。
{"title":"Current State of Healthcare Robots for Older Adults in Care Facilities in Japan and the Related Ethical Issues for Nurses.","authors":"Yuko Yasuhara","doi":"10.2152/jmi.72.8","DOIUrl":"https://doi.org/10.2152/jmi.72.8","url":null,"abstract":"<p><p>This review discusses the introduction of healthcare robots, such as those that provide transfer, toileting, bathing, and communication assistance, in Japanese facilities for older adults and considers these issues from the perspective of nursing ethics. Although healthcare robots can support older adults and their caregivers, they may cause ethical dilemmas when introduced in assisted living facilities. Nurses should make ethical decisions by considering different types of information to determine the best care for older adults ; they can resolve ethical dilemmas by referring to the 6 principles of nursing ethics. As healthcare robots are increasingly used in the care of older adults, nurses should protect patients' rights and ensure patient safety. Further, engineers and medical professionals must discuss and share issues related to the use of healthcare robots to build improved robotic technology for older adults. J. Med. Invest. 72 : 8-13, February, 2025.</p>","PeriodicalId":46910,"journal":{"name":"JOURNAL OF MEDICAL INVESTIGATION","volume":"72 1.2","pages":"8-13"},"PeriodicalIF":0.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144004216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JOURNAL OF MEDICAL INVESTIGATION
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1